Connect to MCP

Claude DesktopClaude Code (CLI)ChatGPTCursorVS Code

Seyitler Kimya Sanayi Valuation Multiples

Seyitler Kimya Sanayi is valued at $12M as of September 2026, a 1.4x revenue multiple. In the last fiscal year, Seyitler Kimya Sanayi revenue was $5M and Seyitler Kimya Sanayi EBITDA was $286K.

See full Seyitler Kimya Sanayi profile

Seyitler Kimya Sanayi Overview

About Seyitler Kimya Sanayi

Seyitler Kimya Sanayi AS is engaged in manufacturing Medical plaster, first aid plaster, and capsicum perforated rheumatism plaster. Its products include Medical Tapes, Medical fluids, Wound Dressing, First-Aid plaster and Eye products among others.

Founded

1991

HQ

Turkey

Employees

56

Financials (Last FY)

Revenue: $5M
EBITDA: $286K

EV

$7M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Seyitler Kimya Sanayi Financials

Seyitler Kimya Sanayi reported last fiscal year revenue of $5M and EBITDA of $286K.

In the same fiscal year, Seyitler Kimya Sanayi generated $2M in gross profit, $286K in EBITDA, and had net loss of ($808K).

Seyitler Kimya Sanayi P&L

In the most recent fiscal year, Seyitler Kimya Sanayi reported revenue of $5M and EBITDA of $286K.

Seyitler Kimya Sanayi is unprofitable as of last fiscal year, with gross margin of 30%, EBITDA margin of 6%, and net margin of (16%).

See analyst estimates for Seyitler Kimya Sanayi
Last FY2025202620272028
Revenue$5M$5M
Gross Profit$2M$2M
Gross Margin30%30%
EBITDA$286K$286K
EBITDA Margin6%6%
EBIT Margin(8%)(8%)
Net Profit($808K)($808K)
Net Margin(16%)(16%)
Net Debt($206K)-

Financial data powered by Morningstar, Inc.

Seyitler Kimya Sanayi Stock Performance

Seyitler Kimya Sanayi has current market cap of $12M, and enterprise value of $7M.

Seyitler Kimya Sanayi's stock price is $0.06.

See more trading valuation data for Seyitler Kimya Sanayi
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$7M$12M-4.5%---$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Seyitler Kimya Sanayi Valuation Multiples

Seyitler Kimya Sanayi trades at 1.4x EV/Revenue multiple, and 23.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Seyitler Kimya Sanayi

Seyitler Kimya Sanayi Financial Valuation Multiples

As of September 24, 2026, Seyitler Kimya Sanayi has market cap of $12M and EV of $7M.

Seyitler Kimya Sanayi has a P/E ratio of (15.3x).

Last FY2025202620272028
EV/Revenue1.4x1.4x
EV/EBITDA23.9x23.9x
EV/EBIT(16.7x)(16.7x)
EV/Gross Profit4.6x4.6x
P/E(15.3x)(15.3x)
EV/FCF4.6x4.6x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Seyitler Kimya Sanayi Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Seyitler Kimya Sanayi Margins & Growth Rates

In the most recent fiscal year, Seyitler Kimya Sanayi reported gross margin of 30%, EBITDA margin of 6%, and net margin of (16%).

See estimated margins and future growth rates for Seyitler Kimya Sanayi

Seyitler Kimya Sanayi Margins

Last FY2025202720282029
Gross Margin30%30%
EBITDA Margin6%6%
EBIT Margin(8%)(8%)
Net Margin(16%)(16%)
FCF Margin30%30%

Data powered by FactSet, Inc. and Morningstar, Inc.

Seyitler Kimya Sanayi Operational KPIs

Seyitler Kimya Sanayi's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Seyitler Kimya Sanayi
Last FY2025202620272028
Revenue per Employee$0.1M-
Opex per Employee$0.0M-
S&M Expenses to Revenue7%7%
G&A Expenses to Revenue3%3%
Opex to Revenue39%39%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Digital TherapeuticsHorizontal MarketplacesInvestment BankingERP SoftwareDeveloper ToolsConsumer SaaSStreamingVertical SaaSNetworking HardwareFinancial Data & InformationEnergy StorageRoad InfrastructureSemiconductors
Explore Valuation Multiples by Industry

Seyitler Kimya Sanayi Competitors

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E

This data is available for Pro users. Sign up to see all Seyitler Kimya Sanayi competitors and their valuation data.

Start Free Trial

Seyitler Kimya Sanayi VC Funding History

Before going public, Seyitler Kimya Sanayi raised funding across 2 rounds.

Seyitler Kimya Sanayi Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Jan-24SecondaryHedef Portföy--A venture capital investment fund managed by Hedef Portföy bought an 8 per cent stake in the listed medical plaster manufacturer Seyitler Kimya during 2024, acquiring the shares from its sister company Hedef Girişim. The acquiring vehicle was the Hedef Portföy Yönetimi Varlık Girişim Sermayesi Yatırım Fonu, and Hedef Girişim's shareholder tables show the fund holding no shares at the end of 2023 and 16,000,000 shares equal to 8 per cent of Seyitler Kimya's TRY 200 million issued capital at the end of 2024. Over the same period Hedef Girişim's own interest fell from 15,243,901 shares, or 15.24 per cent, to 14,487,802 shares, or 7.24 per cent, as the company's capital was doubled from TRY 100 million to TRY 200 million. Press reporting of the underlying disclosure describes the transfer as 8,000,000 non-publicly traded Seyitler Kimya shares sold by Hedef Girişim to the Varlık fund at TRY 8.77 per share, a figure that predates the capital increase. Seyitler Kimya was founded in İzmir in 1991 by Seyit Derviş Şanlı and manufactures medical plasters, first-aid tapes and capsicum rheumatism plasters for the Turkish market and for export, producing to World Health Organisation and Turkish Ministry of Health standards with ISO 9001 and ISO 13485 certification. Its shares trade on Borsa İstanbul under the ticker SEYKM.
Dec-17Strategic investmentHedef Girişim--Hedef Girişim took a venture capital stake in the İzmir medical plaster manufacturer Seyitler Kimya under a board resolution dated 13 December 2017, subscribing for 5,263,912 nominal shares. The investment was made under article 21 of the Capital Markets Board's III-48.3 communiqué on venture capital investment trusts, which allows a trust to invest in companies of this type, and it was the trust's first sizeable industrial holding. Hedef Girişim built the position further over the following years: after Seyitler Kimya carried out a bonus issue on 28 September 2018 that lifted its capital to TRY 16 million, the trust held 9,512,796.5 nominal shares equal to 59.45 per cent of the company at the end of 2018, and it still held 30.35 per cent at the end of 2021 before the stake was progressively diluted and partly sold down. No price was disclosed for the original subscription. Seyitler Kimya was founded in İzmir in 1991 by Seyit Derviş Şanlı and manufactures medical plasters, first-aid tapes and capsicum rheumatism plasters for sale in Turkey and for export, producing to World Health Organisation and Turkish Ministry of Health standards and holding ISO 9001 and ISO 13485 certification and CE declarations for its products. The company's issued capital rose from TRY 16 million in 2018 to TRY 200 million by the end of 2024, and its shares trade on Borsa İstanbul under the ticker SEYKM. Namık Kemal Gökalp, the controlling shareholder of the Hedef group, holds the privileged A group shares in the company alongside the trust's B group holding.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Seyitler Kimya Sanayi

When was Seyitler Kimya Sanayi founded?Seyitler Kimya Sanayi was founded in 1991.
Where is Seyitler Kimya Sanayi headquartered?Seyitler Kimya Sanayi is headquartered in Turkey.
How many employees does Seyitler Kimya Sanayi have?As of today, Seyitler Kimya Sanayi has over 56 employees.
Is Seyitler Kimya Sanayi publicly listed?Yes, Seyitler Kimya Sanayi is a public company listed on Borsa Istanbul.
What is the stock symbol of Seyitler Kimya Sanayi?Seyitler Kimya Sanayi trades under SEYKM ticker.
When did Seyitler Kimya Sanayi go public?Seyitler Kimya Sanayi went public in 2015.
Who are competitors of Seyitler Kimya Sanayi?Seyitler Kimya Sanayi main competitors include
What is the current market cap of Seyitler Kimya Sanayi?Seyitler Kimya Sanayi's current market cap is $12M.
What is the current revenue of Seyitler Kimya Sanayi?Seyitler Kimya Sanayi's last fiscal year revenue is $5M.
What is the current EV/Revenue multiple of Seyitler Kimya Sanayi?Current revenue multiple of Seyitler Kimya Sanayi is 1.4x.
Is Seyitler Kimya Sanayi profitable?No, Seyitler Kimya Sanayi is not profitable.
How many companies Seyitler Kimya Sanayi has acquired to date?Seyitler Kimya Sanayi hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Seyitler Kimya Sanayi has invested to date?Seyitler Kimya Sanayi hasn't invested in any companies yet (or none have been disclosed publicly).

Lists including Seyitler Kimya Sanayi

Largest Companies in Turkey

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial